113 related articles for article (PubMed ID: 10794922)
1. Mapping PET-measured triamcinolone acetonide (TAA) aerosol distribution into deposition by airway generation.
Lee Z; Berridge MS; Finlay WH; Heald DL
Int J Pharm; 2000 Apr; 199(1):7-16. PubMed ID: 10794922
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary distribution and kinetics of inhaled [11C]triamcinolone acetonide.
Berridge MS; Lee Z; Heald DL
J Nucl Med; 2000 Oct; 41(10):1603-11. PubMed ID: 11037987
[TBL] [Abstract][Full Text] [Related]
3. Deposition and pharmacokinetics of an HFA formulation of triamcinolone acetonide delivered by pressurized metered dose inhaler.
Hirst PH; Pitcairn GR; Richards JC; Rohatagi S; Gillen MS; Newman SP
J Aerosol Med; 2001; 14(2):155-65. PubMed ID: 11681648
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo techniques used in drug development for evaluation of dose delivery of inhaled corticosteroids.
Rhodes GR; Rohatagi S; Gillen MS; Deluccia F; Banerji DD; Chaikin P
J Clin Pharmacol; 2001 Jan; 41(1):7-18. PubMed ID: 11144996
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution and kinetics of nasal carbon-11-triamcinolone acetonide.
Berridge MS; Heald DL; Muswick GJ; Leisure GP; Voelker KW; Miraldi F
J Nucl Med; 1998 Nov; 39(11):1972-7. PubMed ID: 9829591
[TBL] [Abstract][Full Text] [Related]
6. Inhaled Aerosol Distribution in Human Airways: A Scintigraphy-Guided Study in a 3D Printed Model.
Verbanck S; Ghorbaniasl G; Biddiscombe MF; Dragojlovic D; Ricks N; Lacor C; Ilsen B; de Mey J; Schuermans D; Underwood SR; Barnes PJ; Vincken W; Usmani OS
J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):525-533. PubMed ID: 27337643
[TBL] [Abstract][Full Text] [Related]
7. In vivo characterization of inhaled pharmaceuticals using quantitative positron emission tomography.
Berridge MS; Heald DL
J Clin Pharmacol; 1999 Aug; 39(S1):25S-29S. PubMed ID: 10434244
[No Abstract] [Full Text] [Related]
8. Assessing lung deposition of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at the Institute of Biology, London, U.K. on 17 April 1998.
Snell NJ; Ganderton D
Respir Med; 1999 Feb; 93(2):123-33. PubMed ID: 10464864
[TBL] [Abstract][Full Text] [Related]
9. Aerosol characterization of nebulized intranasal glucocorticoid formulations.
Berlinski A; Waldrep JC
J Aerosol Med; 2001; 14(2):237-44. PubMed ID: 11681655
[TBL] [Abstract][Full Text] [Related]
10. A study comparing the clinical pharmacokinetics, pharmacodynamics, and tolerability of triamcinolone acetonide HFA-134a metered-dose inhaler and budesonide dry-powder inhaler following inhalation administration.
Argenti D; Shah B; Heald D
J Clin Pharmacol; 2000 May; 40(5):516-26. PubMed ID: 10806605
[TBL] [Abstract][Full Text] [Related]
11. The effect of scatter and attenuation on aerosol deposition as determined by gamma scintigraphy.
Lee Z; Berridge MS; Nelson AD; Heald DL
J Aerosol Med; 2001; 14(2):167-83. PubMed ID: 11681649
[TBL] [Abstract][Full Text] [Related]
12. Controlled, Parametric, Individualized, 2-D and 3-D Imaging Measurements of Aerosol Deposition in the Respiratory Tract of Asthmatic Human Subjects for Model Validation.
Fleming J; Conway J; Majoral C; Katz I; Caillibotte G; Pichelin M; Montesantos S; Bennett M
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):432-51. PubMed ID: 25859710
[TBL] [Abstract][Full Text] [Related]
13. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
Kolanjiyil AV; Kleinstreuer C; Sadikot RT
Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
[TBL] [Abstract][Full Text] [Related]
14. Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size.
Usmani OS; Biddiscombe MF; Barnes PJ
Am J Respir Crit Care Med; 2005 Dec; 172(12):1497-504. PubMed ID: 16192448
[TBL] [Abstract][Full Text] [Related]
15. Influence of micronization method on the performance of a suspension triamcinolone acetonide pressurized metered-dose inhaler formulation.
Williams RO; Brown J; Liu J
Pharm Dev Technol; 1999 May; 4(2):167-79. PubMed ID: 10231878
[TBL] [Abstract][Full Text] [Related]
16. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.
Van Holsbeke C; De Backer J; Vos W; Marshall J
Ther Adv Respir Dis; 2018; 12():1753466618760948. PubMed ID: 29499614
[TBL] [Abstract][Full Text] [Related]
17. Comparison of SPECT aerosol deposition data with a human respiratory tract model.
Fleming JS; Epps BP; Conway JH; Martonen TB
J Aerosol Med; 2006; 19(3):268-78. PubMed ID: 17034303
[TBL] [Abstract][Full Text] [Related]
18. Comparative performance of two inhaler systems to assess distribution of convective ventilation by 99mTc-labeled aerosol scintigraphy in patients with airway obstruction.
Fazzi P; Borsò E; Albertelli R; Mariani G; Giuntini C
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):428-36. PubMed ID: 19174757
[TBL] [Abstract][Full Text] [Related]
19. Current Inhalers Deliver Very Small Doses to the Lower Tracheobronchial Airways: Assessment of Healthy and Constricted Lungs.
Walenga RL; Longest PW
J Pharm Sci; 2016 Jan; 105(1):147-59. PubMed ID: 26852850
[TBL] [Abstract][Full Text] [Related]
20. Methods of calculating lung delivery and deposition of aerosol particles.
Kim CS
Respir Care; 2000 Jun; 45(6):695-711. PubMed ID: 10894462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
